End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,720 KRW | -2.11% | -11.32% | -29.55% |
2023 | U2Bio Co., Ltd. has filed an IPO. | CI |
2020 | Chang Moo Jeon acquired 8.5% stake in U2Bio CO. LTD. from MAC Fund, L.P. (Class B), a fund managed by M-Venture Investment, Inc. for KRW 1.6 billion. | CI |
1 day | -2.11% | ||
1 week | -11.32% | ||
Current month | -17.33% | ||
1 month | -3.75% | ||
3 months | -15.55% | ||
6 months | -31.11% | ||
Current year | -29.55% |
Managers | Title | Age | Since |
---|---|---|---|
Jin-Tae Kim
CEO | Chief Executive Officer | 60 | 09-10-31 |
Ji-Won Kim
CTO | Chief Tech/Sci/R&D Officer | 53 | 10-12-31 |
Hyuk-Sung Jin
BRD | Director/Board Member | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jang-Ho Park
BRD | Director/Board Member | 53 | - |
Jin-Tae Kim
CEO | Chief Executive Officer | 60 | 09-10-31 |
Ji-Won Kim
CTO | Chief Tech/Sci/R&D Officer | 53 | 10-12-31 |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.55% | 30.22M | |
+25.01% | 88.62B | |
-22.75% | 76.58B | |
+3.24% | 26.87B | |
-8.76% | 17.48B | |
+1.00% | 17.11B | |
+0.23% | 15.35B | |
+78.95% | 13.21B | |
+71.14% | 13.16B | |
-24.74% | 12.98B |
- Stock Market
- Equities
- A221800 Stock